Testing effectiveness (Phase 2)Study completedNCT04530123
What this trial is testing
Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet
Who this might be right for
Celiac Disease
Takeda 102